Cambridge, MA, United States of America

Pei Ge

USPTO Granted Patents = 2 

Average Co-Inventor Count = 4.7

ph-index = 1


Company Filing History:


Years Active: 2015-2025

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Pei Ge: Innovator in Neurological Treatment

Introduction

Pei Ge is a prominent inventor based in Cambridge, MA (US). She has made significant contributions to the field of medical treatment, particularly in addressing neurological disorders. With a total of 2 patents, her work focuses on innovative solutions that enhance patient care and treatment efficacy.

Latest Patents

Pei Ge's latest patents include groundbreaking inventions aimed at treating nucleotide repeat expansion disorders associated with MSH3 activity. The first patent features useful compositions and methods designed to treat these disorders in subjects in need. The second patent provides treatment compositions and methods for neurological disorders. This invention includes a labeled interfering RNA (iRNA) agent that decreases the expression of target RNA associated with the disorder. The methods involve introducing a solution containing a tracer into the brain of a mammal, allowing for the monitoring of the therapeutic composition's delivery rate.

Career Highlights

Throughout her career, Pei Ge has worked with notable companies such as Takeda Pharmaceuticals U.S.A., Inc. and Medtronic, Inc. Her experience in these organizations has contributed to her expertise in developing innovative medical treatments.

Collaborations

Pei Ge has collaborated with esteemed colleagues, including Nessan Anthony Bermingham and Brian R Bettencourt. These partnerships have fostered a collaborative environment that enhances the development of her inventions.

Conclusion

Pei Ge's contributions to the field of neurological treatment through her patents and collaborations highlight her role as an influential inventor. Her work continues to pave the way for advancements in medical science and patient care.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…